Hila Karah

Hila is a Managing Partner of the HealthTech fund at Pitango, a global investment firm founded in 1993. She brings over 20 years of life science experience to her role, including time spent as a consultant advising on business strategy. Prior to Pitango, Hila was a Chief Investment Officer of Eurotrust Ltd., a Partner Senior Analyst at Perceptive Life Sciences Ltd., and VP Research at Oracle Partners Ltd. In addition to Variantyx, Hilla currently serves on the Board of Directors for Indaptus Therapeutics Ltd. (NASDAQ: INDP), Dario Health Corp. (NASDAQ: DRIO) and OncoHost Ltd. She also volunteers as an oncology case manager and serves as a professional manager at Mifrasim, a NOP social venture. Hila received a BA in molecular and cell biology from the University of California, Berkeley, and has studied as part of the UC Berkeley-UCSF joint medical program.